Home Drug Codes J Codes J2770 · SYNERCID
Updated July 1st, 2026

SYNERCID J Code: J2770

Injection, quinupristin/dalfopristin, 500 mg (150/350)

Login to unlock all benchmarks
Medicare Payment Limit ?
Not published
CMS publishes none for Q3 2026
APC Payment Limit ?
Not published
CMS publishes none for Q3 2026
ASP ?
No current ASP
Not available for Q3 2026
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
1
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, quinupristin/dalfopristin, 500 mg (150/350)
HCPCS Added Date January 1, 2001
Manufacturer Pfizer
Generic Status Multi-Source; Generic

About SYNERCID

Synercid is a medication aligned to the HCPCS J Code: J2770 for billing, pricing, and reimbursement purposes in the United States. It is an Antibiotic drug manufactured by Pfizer.

Manufacturers, reach out to us to add more information.

NDC Code Information

1 NDC package is crosswalked to J2770. Package detail is available to logged-in subscribers.

Login to view 1 NDC package View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

SYNERCID Medically Unlikely Edits (MUE)

The most billing units of J2770 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 500 mg. The limit is different in the office and the hospital. Use the one for your setting.

Practitioner Office
6 units / day
= 3,000 mg per day
Hospital Outpatient
7 units / day
= 3,500 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.
Not on the CMS JW / JZ list

CMS does not include Synercid (J2770) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J2770. Wastage billing guide →

SYNERCID Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Serious or life-threatening infections associated with vancomycin-resistant Enterococcus faecium (VREF) bacteremia Complicated skin and skin structure infections due to Staphylococcus aureus (methicillin-susceptible) or Streptococcus pyogenes

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Synercid billing and coding guide?
Our team has not identified a manufacturer-published source of billing and coding information for SYNERCID.
Are there any available Synercid patient assistance programs?
SYNERCID patient assistance information can be found through Pfizer. Visit Here →
Where can I find Synercid prescribing information?
SYNERCID prescribing information can be found at the link below: Visit Here →
Where can I find Synercid side effect information?
Information regarding SYNERCID's side effects can be found at MedlinePlus Visit Here →
Does billing SYNERCID require JZ/JW wastage modifiers?
CMS does not include SYNERCID (J2770) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J2770. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.